Medtronic EBITDA Margin 2010-2024 | MDT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of January 31, 2024 is .
| Medtronic EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-01-31 | $32.32B | $8.33B | 25.78% |
| 2023-10-31 | $31.96B | $8.27B | 25.88% |
| 2023-07-31 | $31.56B | $8.33B | 26.40% |
| 2023-04-30 | $31.23B | $8.18B | 26.20% |
| 2023-01-31 | $30.77B | $8.30B | 26.96% |
| 2022-10-31 | $30.81B | $8.56B | 27.78% |
| 2022-07-31 | $31.07B | $8.72B | 28.07% |
| 2022-04-30 | $31.69B | $8.46B | 26.70% |
| 2022-01-31 | $31.79B | $8.39B | 26.39% |
| 2021-10-31 | $31.80B | $8.01B | 25.20% |
| 2021-07-31 | $31.60B | $7.37B | 23.34% |
| 2021-04-30 | $30.12B | $7.19B | 23.86% |
| 2021-01-31 | $27.93B | $5.89B | 21.08% |
| 2020-10-31 | $27.87B | $6.23B | 22.37% |
| 2020-07-31 | $27.93B | $6.65B | 23.83% |
| 2020-04-30 | $28.91B | $7.45B | 25.78% |
| 2020-01-31 | $31.06B | $9.08B | 29.23% |
| 2019-10-31 | $30.89B | $8.99B | 29.12% |
| 2019-07-31 | $30.67B | $9.17B | 29.89% |
| 2019-04-30 | $30.56B | $8.93B | 29.21% |
| 2019-01-31 | $30.56B | $8.91B | 29.15% |
| 2018-10-31 | $30.38B | $8.79B | 28.94% |
| 2018-07-31 | $29.95B | $9.17B | 30.61% |
| 2018-04-30 | $29.95B | $9.28B | 31.00% |
| 2018-01-31 | $29.73B | $9.07B | 30.52% |
| 2017-10-31 | $29.64B | $8.86B | 29.88% |
| 2017-07-31 | $29.93B | $8.41B | 28.09% |
| 2017-04-30 | $29.71B | $8.30B | 27.94% |
| 2017-01-31 | $29.36B | $8.21B | 27.96% |
| 2016-10-31 | $29.01B | $8.40B | 28.96% |
| 2016-07-31 | $28.73B | $8.28B | 28.83% |
| 2016-04-30 | $28.83B | $8.21B | 28.47% |
| 2016-01-31 | $28.57B | $6.76B | 23.67% |
| 2015-10-31 | $25.95B | $6.24B | 24.03% |
| 2015-07-31 | $23.26B | $5.63B | 24.22% |
| 2015-04-30 | $20.26B | $5.15B | 25.41% |
| 2015-01-31 | $17.52B | $4.83B | 27.55% |
| 2014-10-31 | $17.37B | $4.52B | 26.01% |
| 2014-07-31 | $17.20B | $4.54B | 26.39% |
| 2014-04-30 | $17.01B | $4.67B | 27.47% |
| 2014-01-31 | $16.90B | $5.58B | 33.04% |
| 2013-10-31 | $16.76B | $5.80B | 34.59% |
| 2013-07-31 | $16.67B | $5.79B | 34.71% |
| 2013-04-30 | $16.59B | $5.68B | 34.23% |
| 2013-01-31 | $16.43B | $5.68B | 34.58% |
| 2012-10-31 | $16.32B | $5.61B | 34.37% |
| 2012-07-31 | $16.25B | $5.66B | 34.81% |
| 2012-04-30 | $16.18B | $5.67B | 35.01% |
| 2012-01-31 | $15.86B | $5.47B | 34.45% |
| 2011-10-31 | $15.80B | $5.46B | 34.57% |
| 2011-07-31 | $15.68B | $5.35B | 34.14% |
| 2011-04-30 | $15.51B | $5.27B | 34.00% |
| 2011-01-31 | $15.30B | $5.34B | 34.90% |
| 2010-10-31 | $15.30B | $5.46B | 35.71% |
| 2010-07-31 | $15.23B | $5.56B | 36.53% |
| 2010-04-30 | $15.39B | $5.65B | 36.73% |
| 2010-01-31 | $15.45B | $5.23B | 33.82% |
| 2009-10-31 | $15.09B | $4.91B | 32.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $105.230B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
| Stryker (SYK) | United States | $128.469B | 31.85 |
| Boston Scientific (BSX) | United States | $99.939B | 33.23 |
| EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
| ResMed (RMD) | United States | $27.191B | 27.18 |
| Terumo (TRUMY) | Japan | $25.327B | 35.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
| Baxter (BAX) | United States | $20.095B | 14.66 |
| Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
| Insulet (PODD) | United States | $12.094B | 63.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.151B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
| BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
| Haemonetics (HAE) | United States | $4.275B | 21.86 |
| Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
| Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Envista Holdings (NVST) | United States | $3.399B | 12.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
| QuidelOrtho (QDEL) | United States | $2.695B | 9.78 |
| Neogen (NEOG) | United States | $2.634B | 25.33 |
| Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
| ICU Medical (ICUI) | United States | $2.347B | 17.51 |
| TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
| Owens & Minor (OMI) | United States | $1.903B | 18.27 |
| Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
| InMode (INMD) | Israel | $1.480B | 7.66 |
| National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
| LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
| AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
| Warby Parker (WRBY) | United States | $1.241B | 0.00 |
| AtriCure (ATRC) | United States | $1.117B | 0.00 |
| MacroGenics (MGNX) | United States | $1.044B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| Evolus (EOLS) | United States | $0.698B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
| Jin Medical (ZJYL) | China | $0.673B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
| Quanterix (QTRX) | United States | $0.610B | 0.00 |
| Valneva SE (VALN) | France | $0.556B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| PetIQ (PETQ) | United States | $0.477B | 17.80 |
| ZimVie (ZIMV) | United States | $0.427B | 26.15 |
| Biote (BTMD) | United States | $0.426B | 4.05 |
| OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
| Zynex (ZYXI) | United States | $0.391B | 45.00 |
| Surmodics (SRDX) | United States | $0.379B | 40.92 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
| Veru (VERU) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
| Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
| InterCure (INCR) | Israel | $0.108B | 18.23 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.12 |
| Safety Shot (SHOT) | United States | $0.102B | 0.00 |
| MariMed (MRMD) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Brainsway (BWAY) | Israel | $0.085B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.91 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |